Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung Cancer
August 16, 2023 10:56 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners
July 06, 2023 10:08 ET
|
The Insight Partners
Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...
Cancer Biomarkers Market revenue to cross USD 33 Billion by 2033, says Research Nester
July 05, 2023 08:11 ET
|
Research Nester
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The global cancer biomarkers market is estimated to grow at a CAGR of ~14% from 2023 to 2033. The market is estimated to garner a revenue of nearly USD 33...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Medical Properties Trust, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MPW
April 23, 2023 18:41 ET
|
The Rosen Law Firm PA
NEW YORK, April 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Medical Properties Trust, Inc. (“MPT”) (NYSE: MPW)...
Global Cancer Stem Cells Market Predicted to Register a Revenue of $1,722.7 Million and Grow at a CAGR of 10.3% Over the Estimated Timeframe 2019-2026 [180-Pages] | Released by Research Dive
April 12, 2023 09:02 ET
|
Research Dive
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 03, 2023 07:00 ET
|
FibroGen, Inc.
- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
Atari Announces Acquisition of 12 Classic Arcade Properties, Including Berzerk and Frenzy
March 16, 2023 17:10 ET
|
Atari Inc.
NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- Atari® — one of the world's most iconic consumer brands and interactive entertainment producers — announced today the acquisition of a dozen retro arcade...
Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
March 09, 2023 08:00 ET
|
Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity
March 05, 2023 18:30 ET
|
Immuneering Corporation
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutation Phase 1/2a clinical trial with IMM-1-104 underway in patients with advanced solid...
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 02, 2023 10:00 ET
|
NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...